ADVERTISEMENT
ISET 2023
Endograft Durability 30 Years Later; Results From the PROMISE II U.S. Pivotal Trial
Daniel Clair, MD
Vanderbilt University Medical Center, Nashville, Tennessee
02/23/2023
In this video from ISET 2023, Dr. Daniel Clair from Vanderbilt University Medical Center in Nashville, Tennessee, discusses his presentations on endograft durability and results of the PROMISE II trial, which investigated the safety and effectiveness of the LimFlow System for creating an AV connection in the BTK vascular system using an endovascular, minimally invasive approach to arterialize the pedal veins for the treatment of CLTI.
Advertisement
Specialties
Events
Year Round Education
HMP Global Products
Advertisement
Advertisement